Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesWhen patients' BP just won't come down
The Clinical Advisor, 07/16/09
Sherman C - Uncontrolled hypertension remains a taxing clinical problem. Various surveys reveal that <=50% of patients under treatment achieve target BPs (<140/90 mm Hg; 130/80 for those with diabetes or chronic kidney disease). A substantial proportion of patients (exact number uncertain) suffer from "resistant hypertension," i.e., their BP remains elevated despite concurrent use of three agents of different classes. In its first Scientific Statement to focus on this issue, the American Heart Association (AHA) stresses the need for evaluation that spreads a broad net to identify contributing and secondary causes and treatment options that go beyond the usual antihypertensives.
Related Articles
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 68%
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 68%
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension. Inter-American Society of Hypertension
Hypertension, 10/29/09
Relevance Score: 67%
Practical strategies for management of hypertension in the elderly
Geriatrics, 10/21/09
Relevance Score: 67%
Current options for the treatment of resistant hypertension
Expert Review of Cardiovascular Therapy, 11/13/09
Relevance Score: 65%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
International Journal of Women's Health, 11/30/09
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Clinical Interventions in Aging, 11/30/09
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Vascular Health and Risk Management, 11/30/09
Today in Family Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
EAU Guidelines on Chronic Pelvic Pain
European Urology, 11/30/09
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Clinical Interventions in Aging, 11/30/09
Antiangiogenic Drugs in Oncology: A Focus on Drug Safety and the Elderly - A Mini-Review
Gerontology, 11/30/09
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of Environmental Tobacco Smoke Exposure in Childhood With Early Emphysema in Adulthood Among Nonsmokers
American Journal of Epidemiology, 11/30/09
Quasi-experimental evidence on the causal effects of physical health on mental health
International Journal of Epidemiology, 11/30/09
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor